Zhongming Zhang

1 clinical trials · Sponsor

Record	Firm	Date
Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major (NCT02342145)	Zhongming Zhang	2015-04-01

Every clearance here is in the API, with alerts when new ones post.